-
公开(公告)号:AT192738T
公开(公告)日:2000-05-15
申请号:AT97103163
申请日:1997-02-27
Applicant: HOECHST AG
Inventor: HEITSCH HOLGER DR , WAGNER ADALBERT DR , WIRTH KLAUS DR , SCHOELKENS BERNWARD PROF DR , NOELKEN GERHARD DR
IPC: C07D215/48 , A61K31/47 , A61P43/00 , C07D215/26
Abstract: 8-(3-(Aminoalkoxy)-benzyloxy)-quinoline compounds of formula (I) and their salts are new. R1-R3 = H, halo, CHO, COOH, 1-5C alkyl, 6-10C aryl, 1-3C alkyl-(6-10C) aryl, 3-8C cycloalkyl or 1-3C alkoxycarbonyl; R4, R5 = H, halo, NO2, CN, 1-3C alkoxy or 1-3C alkylthio; R6 = H, 1-3C alkyl, 3-5C alkylalkenyl (sic) or 1-3C alkyl-6-10C aryl; R7 = H, 1-6C alkanoyl, alkanoyl (substituted by 1-3C alkoxy, alkylcarbamoyl or aryl), 3-7C alkenoyl, 3-8C cycloalkylcarbonyl, 5-7C cycloalkenylcarbonyl, 1-3C alkoxycarbonyl, aryloxycarbonyl, 6-12C aroyl (optionally substituted by 1-3C alkoxy or halo), alkenoyl (substituted by aryl (optionally substituted by 1-3C alkoxy, 1-3C alkylenedioxy, NO2, CN, halo, 1-3C haloalkyl, hetero-3-8C cycloalkyl (sic), NH2, 1-4C alkylamino, 6-12C heteroaryl-alkanoylamino, aroylamino, 6-12C heteroarylcarbonylamino, 1-5C alkylsulphonylamino, 1-5C alkylureido, alkanoyl, 1-5C alkoxycarbonyl, 1-5C alkylcarbamoyl or arylcarbamoyl), 2-5C acylamino-arylcinnamoyl, 1-3C alkoxycarbonylamino-arylcinnamoyl, 1-4C alkylaminocarbonylaminocinnamoyl, aryl-1-5C alkoxycarbonyl, 1-5C alkylcarbamoyl, arylcarbamoyl, aroylcarbamoyl, alkylsulphonyl, arylsulphonyl, aryl-alkylsulphonyl or phthaloyl (for R6=R7(sic)); n = 1-8; alkyl has 1-6C, aryl has 6-12C, alkanoyl has 2-6C, and alkenoyl has 3-6C unless specified other wise.
-
公开(公告)号:AT183732T
公开(公告)日:1999-09-15
申请号:AT94100048
申请日:1994-01-04
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT DR , BHATNAGAR NEERJA DR , BUENDIA JEAN DR , GRIFFOUL CHRISTINE DR
IPC: B01J23/44 , A61K31/235 , A61K31/41 , C07B37/04 , C07B61/00 , C07C41/48 , C07C45/61 , C07C45/71 , C07C47/546 , C07C67/30 , C07C67/343 , C07C69/76 , C07C69/767 , C07C253/30 , C07C255/37 , C07C255/40 , C07C255/56 , C07C303/40 , C07C311/09 , C07C311/48 , C07C311/51 , C07C311/52 , C07C311/53 , C07C311/54 , C07C311/57 , C07C311/58 , C07D257/04
Abstract: The invention relates to a method for the preparation of a compound of the general formula (I) in which X represents an optionally protected formyl group and R denotes a group which is itself inert to the reaction conditions of the synthesis, for example -CN, characterised in that a compound of the general formula (II) where X is as defined above, is reacted with a substituted phenyl halogen compound of the formula (III) where Hal denotes e.g. bromine. The compounds are useful intermediates for pharmaceutical synthesis.
-
公开(公告)号:DE19712960A1
公开(公告)日:1998-10-01
申请号:DE19712960
申请日:1997-03-27
Applicant: HOECHST AG
Inventor: HEITSCH HOLGER DR , WAGNER ADALBERT DR , WIRTH KLAUS DR , SCHOELKENS BERNWARD PROF DR
IPC: C07D215/24 , A61K31/395 , A61K31/47 , A61K31/495 , A61P1/16 , A61P43/00 , C07D215/26 , C07D241/36 , C07D401/12 , C07D405/12 , C07D239/72 , C07D241/40 , C07D237/28 , C07D253/08 , C07D257/10 , A61K31/04 , A61K31/53 , A61K31/50
Abstract: 8-Benzyloxy-(iso)quinoline derivatives (including poly-aza analogues) of formula (I) and their salts are new: D = aza-heterocyclic residue of formula (i) or (ii); X1 = N or CR6; X2 = N or CR7; X3 = N or CR8; B = benzyl variably substituted on the ring by R3-R5; R1, R2 = H, halo or 1-3C alkyl; R3, R4 = H, halo, CN, 1-3C alkyl (optionally substituted by halo), 1-3C alkoxy (optionally substituted by halo), 1-3C alkylthio (optionally substituted by halo), OH, tetrazolyl, CONHR9 or CO2R9; R5 = NO2, NH2, -NR9AYER10 or SO2NR9R10; R6, R8, R'" = H, halo, 1-4C alkyl, 1-4C alkoxy, NH2, NH-(1-4C alkyl), OH, Ar, Ar-(1-4C)-alkanediyl or CO2R9; R7, R', R" = H or 1-4C alkyl; R9 = H, 1-4C alkyl, 2-5C alkenyl or Ar-(1-3C)-alkanediyl; A = divalent residue of an aminocarboxylic acid such as methionine, alanine, phenylalanine, tyrosine, O-methyltyrosine, beta -(2-thienyl)-alanine, glycine, cyclohexylalanine, leucine, isoleucine, valine, norleucine, phenylglycine, serine, cysteine, aminopropionic acid or aminobutyric acid; Y = C=O, C=S or SO2; E = 2-5C alkene-diyl, 1-7C alkanediyl, 3-10C cycloalkanediyl or -(CH2)m-To-(CH2)n (all optionally substituted by one or more groups such as OR12, NO2, CN, CO2R9, NR13R14, SO3R12, SO2NR13R14 or CONR13R14); T = O, S or NR15; m, n = 0-6; o = 0 or 1; p = 1-3; R10 = H or 1-5C alkyl, Ar', Ar'-(1-3C)-alkanediyl or 5-10C heteroaryl (all optionally substituted by one or more groups such as halo, NO2, 1-5C alkylthio, NR13R14, NR13COR16, CO2R9, SO3R12, SO2NR13R14, OR12 or 1-6C alkyl, or Ar', 2-5C alkenyl or OA5 (themselves optionally partially or completely substituted by halo)); R11 = 1-5C alkyl or 1-5C alkoxy (both optionally partially or completely substituted by F or Cl); R12, R13 = H, 1-5C alkyl, 2-5C alkenyl, Ar, Ar-(1-5C)-alkanediyl, 3-10C cycloalkyl, (3-10C)-cycloalkyl-(1-2C)-alkanediyl, CO2-(1-5C alkyl) or CONH-(1-5C alkyl); R14 = H, CO2-(1-3C alkyl) or CO2-(1-3C)-alkanediyl-Ar'; R15 = H, CO2-(1-3C alkyl) or 1-3C alkyl; R16 = 1-3C alkyl, Ar or 5-10C heteroaryl (all optionally substituted by one or more groups such as halo, CN, NO2, NR13R14 or CO2R9); Ar, Ar' = aryl with 6-12C or 6-10C respectively; provided that if D = (ii), then R3 and R4 are not both halo, 1-3C and/or 1-3C alkoxy or H in combination with halo, 1-3C alkyl or 1-3C alkoxy, excluded from this proviso being compounds in which: (a) R5 = -N(R9)-A-Y-E-R10 and R10 = (R11)p-substituted phenyl, provided that if R10 = (R11)p-substituted phenyl then R3 and R4 are not same or different H and halo; and (b) R5 = -SO2NR9R10, provided that R3 and R4 are not both halo.
-
公开(公告)号:CZ154797A3
公开(公告)日:1997-12-17
申请号:CZ154797
申请日:1997-05-20
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT DR , HEITSCH HOLGER DR , NOLKEN GERHARD DR , WIRTH KLAUS DR , SCHOLKENS BERNWARD PROF DR
IPC: C07D277/60 , A61K31/38 , A61K31/395 , A61K31/41 , A61K31/425 , A61K31/428 , A61K31/53 , A61P43/00 , C07D253/10 , C07D277/62 , C07D277/64 , C07D277/66 , C07D277/68 , C07D277/70 , C07D277/74 , C07D277/82 , C07D417/12
Abstract: Sulphur-containing bradykinin antagonist compounds of formula (I) and their salts are claimed: one of X1-X3 = COR , and the other X1-X4 = N, CR ; R ,R = H, halo, 1-6C alkyl, OR , SR , NHR , 6-12C aryl, (6-12C aryl)(1-3C alkyl), C(O)OR , C(O)H, 2-5C alkenyl, NO2, SO3R , CN, C(O)NHR , where alkyl, aryl, alkenyl may be substituted by C(O)(O)o(1-5C alkyl), OR , SR , NO2, CN, NHR , halo; R = (II); R ,R = e.g. H; R -R = H, 1-5C alkyl, 3-5C alkenyl, etc.; A = amino acid e.g. methionine, alanine, phenylalanine, etc.; R = H, C(O)(O)o(1-5C alkyl), C(O)(O)o(11-3C alkyl)(6-10C aryl); R = e.g. C(O)DE; D = 2-5C alkendiyl, 1-8C alkandiyl, (CH2)nYo(CH2)m, etc., where any of the groups are optionally substituted by e.g. OR ; E = H, 6-10C aryl, 1-9C heteroaryl, etc.;Y = O, S, NR ; n,m = 0-6; o = 0 or 1.
-
公开(公告)号:DK0450566T3
公开(公告)日:1995-10-30
申请号:DK91105178
申请日:1991-04-02
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT DR , HENNING RAINER DR , GERHARDS HERMANN DR , SCHOELKENS BERNWARD DR , JEAN-PAUL VEVERT , JEAN-CLAUDE CAILLE
IPC: A61K31/415 , A61K31/38 , A61K31/40 , A61K31/41 , A61K31/4155 , A61K31/4164 , A61K31/423 , A61K31/437 , A61K31/44 , A61K31/443 , A61K31/4433 , A61K31/495 , A61K31/505 , A61K31/519 , A61P9/12 , A61P29/00 , A61P43/00 , C07D233/64 , C07D233/84 , C07D233/90 , C07D403/06 , C07D405/06 , C07D409/06 , C07D409/14 , C07D413/06 , C07D471/04 , C07D487/04
Abstract: The invention relates to compounds of the formula in which X, Y and Z are identical or different and are N or CR , R and R are as defined in the description, L is an alkylene radical, q = 0 or 1, and A is the radical of a fused heterobicycle. The invention furthermore relates to a method for the preparation of the abovementioned compounds, to compositions containing them, and to their use.
-
公开(公告)号:BR9400018A
公开(公告)日:1994-07-26
申请号:BR9400018
申请日:1994-01-04
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT DR , BHATNAGAR NEERJA , BUENDIA JEAN , GRIFFOUL CHRISTINE
IPC: B01J23/44 , A61K31/235 , A61K31/41 , C07B37/04 , C07B61/00 , C07C41/48 , C07C45/61 , C07C45/71 , C07C47/546 , C07C67/30 , C07C67/343 , C07C69/76 , C07C69/767 , C07C253/30 , C07C255/37 , C07C255/40 , C07C255/56 , C07C303/40 , C07C311/09 , C07C311/48 , C07C311/51 , C07C311/52 , C07C311/53 , C07C311/54 , C07C311/57 , C07C311/58 , C07D257/04 , C07C311/39 , C07C311/63 , A61K31/18 , A61K31/64
Abstract: The invention relates to a method for the preparation of a compound of the general formula (I) in which X represents an optionally protected formyl group and R denotes a group which is itself inert to the reaction conditions of the synthesis, for example -CN, characterised in that a compound of the general formula (II) where X is as defined above, is reacted with a substituted phenyl halogen compound of the formula (III) where Hal denotes e.g. bromine. The compounds are useful intermediates for pharmaceutical synthesis.
-
公开(公告)号:AT100463T
公开(公告)日:1994-02-15
申请号:AT90113712
申请日:1990-07-18
Applicant: HOECHST AG
Inventor: KLEEMANN HEINZ-WERNER DR , URBACH HANSJOERG DR , WAGNER ADALBERT DR , RUPPERT DIETER DR , LINZ WOLFGANG DR , KRAMER WERNER DR DR
IPC: C12N9/99 , A61K31/38 , A61K31/381 , A61K31/415 , A61K31/445 , A61K31/535 , A61K38/55 , A61P9/12 , C07C237/08 , C07C237/22 , C07D211/26 , C07D211/58 , C07D233/54 , C07D233/64 , C07D295/20 , C07D333/24 , C07D401/12 , C07D403/12 , C07D409/12 , C07D521/00 , C07K1/113 , C07K5/06 , C07K5/065 , C07K5/078 , C07K14/81
-
公开(公告)号:AT97912T
公开(公告)日:1993-12-15
申请号:AT87110847
申请日:1987-07-27
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT DR , KLEEMANN HEINZ-WERNER DR , RUPPERT DIETER DR , SCHOELKENS BERNWARD DR
IPC: A61K31/415 , C07D233/64 , C07K1/00 , C07K5/02 , C07K5/06 , A61K37/64
-
公开(公告)号:BR9300761A
公开(公告)日:1993-09-14
申请号:BR9300761
申请日:1993-03-05
Applicant: HOECHST AG
Inventor: HEITSCH HOLGER DR , HENNING RAINER DR , WAGNER ADALBERT DR , GERHARDS HERMANN DR , BECKER REINHARD DR , SCHOELKENS BERNWARD DR
IPC: A61K31/415 , A61K31/4164 , A61K31/64 , A61P9/10 , A61P9/12 , C07D233/84 , C07D233/86 , C07D233/90
Abstract: Compounds of the formula (I) in which R is, for example, ethyl, R is, for example, methyl, n is, for example, zero, R is, for example, COOH and R is, for example, SO2NHCONHCH3 are highly active antagonists of angiotensin II receptors.
-
公开(公告)号:CS1092A3
公开(公告)日:1992-07-15
申请号:CS1092
申请日:1992-01-03
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT DR , ENGLERT HEINRICH DR , KLEEMANN HEINZ-WERNER DR , GERHARDS HERMANN DR , SCHOLKENS BERNWARD PROF DR , BECKER REINHARD DR , LINZ WOLFGANG DR
IPC: A61K31/40 , A61K31/415 , A61K31/425 , A61K31/435 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/445 , A61K31/505 , A61K31/535 , A61K31/54 , A61K31/64 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P13/02 , A61P15/00 , A61P43/00 , C07D207/34 , C07D207/36 , C07D233/54 , C07D233/66 , C07D233/68 , C07D233/70 , C07D233/84 , C07D233/90 , C07D249/02 , C07D255/02 , C07D257/02 , C07D257/04 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D453/02 , C07D521/00 , C07D231/10 , C07D207/30 , C07D249/04 , C07D249/08 , A61K31/41
Abstract: Azole derivative of the general formula (I) in which A, L, O, R , X, Y, Z and q have the meanings given, a process for their preparation, pharmaceutical preparations and the use of the compounds are described. Azole derivatives of the formula I where the symbols have, for example, the following meanings: R = (C2-C10)-alkyl Z = nitrogen X and Y = independently of one another CR L = -CH2- q = zero or 1 A = biphenyl radical which is substituted, for example, by R R = halogen or hydrogen R = SO2-NH-CO-OR and R = phenyl, are highly active antagonists of angiotensin II receptors.
-
-
-
-
-
-
-
-
-